AI tailors cancer cocktail: could this be the end of One-Size-Fits-All chemo?

NCT ID NCT05381038

Recruiting now Disease control Sponsor: National University Hospital, Singapore Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 2 times

Summary

This study tests two AI platforms to personalize cancer treatment for people with solid tumors like gastrointestinal or breast cancer. First, a platform called QPOP analyzes a patient's tumor sample to find the best drug combination. Then, another AI called CURATE.AI adjusts the doses over time based on how the patient responds. The goal is to see if this personalized approach is feasible and can improve treatment effectiveness while reducing side effects.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: azacitidine
What this could lead to: If successful, this could lead to more effective, personalized cancer treatments with fewer side effects by using AI to tailor drug combinations and doses for each patient.
What could go wrong: This is a very small, early-phase feasibility study with only 10 participants. The AI-based approach is experimental and may not work for everyone, or may not improve outcomes compared to standard care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm digestive system cancer digestive system neoplasm gastric cancer neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER GASTROINTESTINAL CANCER SOLID TUMOR

Contacts and locations

Locations

National University Hospital
RECRUITING

Singapore, 119074, Singapore

More trials for these conditions

Other studies related to the condition(s) this trial covers.